Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: Relationship between absolute configuration and subtype selectivity

Kazunori Motoshima; Minoru Ishikawa; Yuichi Hashimoto; Kazuyuki Sugita

doi:10.1016/j.bmc.2011.03.065

Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: Relationship between absolute configuration and subtype selectivity

Kazunori Motoshima, Minoru Ishikawa, Yuichi Hashimoto, Kazuyuki Sugita

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

Introduction of an alkylcarboxylic acid unit, which is a partial structure of endogenous peroxisome proliferator-activated receptor (PPAR) ligands, into a phenethylphenylphthalimide skeleton, which possesses liver X receptor (LXR) antagonistic activity, afforded novel PPAR ligands. The results of structure-activity relationship analysis and docking studies led us to the potent PPAR agonists 13c-e. The absolute configuration of 13c-e affects the PPAR subtype selectivity.

Original language	English
Pages (from-to)	3156-3172
Number of pages	17
Journal	Bioorganic and Medicinal Chemistry
Volume	19
Issue number	10
DOIs	https://doi.org/10.1016/j.bmc.2011.03.065
Publication status	Published - 2011 May 15
Externally published	Yes

Keywords

Molecular design
Nuclear receptor
PPAR agonist
Subtype selectivity

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmc.2011.03.065

Fingerprint

Dive into the research topics of 'Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: Relationship between absolute configuration and subtype selectivity'. Together they form a unique fingerprint.

Cite this

Motoshima, K., Ishikawa, M., Hashimoto, Y., & Sugita, K. (2011). Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: Relationship between absolute configuration and subtype selectivity. Bioorganic and Medicinal Chemistry, 19(10), 3156-3172. https://doi.org/10.1016/j.bmc.2011.03.065

Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists : Relationship between absolute configuration and subtype selectivity. / Motoshima, Kazunori; Ishikawa, Minoru; Hashimoto, Yuichi et al.

In: Bioorganic and Medicinal Chemistry, Vol. 19, No. 10, 15.05.2011, p. 3156-3172.

Research output: Contribution to journal › Article › peer-review

Motoshima, K, Ishikawa, M, Hashimoto, Y & Sugita, K 2011, 'Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: Relationship between absolute configuration and subtype selectivity', Bioorganic and Medicinal Chemistry, vol. 19, no. 10, pp. 3156-3172. https://doi.org/10.1016/j.bmc.2011.03.065

Motoshima, Kazunori ; Ishikawa, Minoru ; Hashimoto, Yuichi et al. / Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists : Relationship between absolute configuration and subtype selectivity. In: Bioorganic and Medicinal Chemistry. 2011 ; Vol. 19, No. 10. pp. 3156-3172.

@article{418a03e3bc3e4fa890d584bc3c8e0239,

title = "Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: Relationship between absolute configuration and subtype selectivity",

abstract = "Introduction of an alkylcarboxylic acid unit, which is a partial structure of endogenous peroxisome proliferator-activated receptor (PPAR) ligands, into a phenethylphenylphthalimide skeleton, which possesses liver X receptor (LXR) antagonistic activity, afforded novel PPAR ligands. The results of structure-activity relationship analysis and docking studies led us to the potent PPAR agonists 13c-e. The absolute configuration of 13c-e affects the PPAR subtype selectivity.",

keywords = "Molecular design, Nuclear receptor, PPAR agonist, Subtype selectivity",

author = "Kazunori Motoshima and Minoru Ishikawa and Yuichi Hashimoto and Kazuyuki Sugita",

note = "Funding Information: The work described in this paper was partially supported by Grants-in-Aid for Scientific Research from The Ministry of Education Culture, Sports, Science and Technology, Japan , and the Japan Society for the Promotion of Science . ",

year = "2011",

month = may,

day = "15",

doi = "10.1016/j.bmc.2011.03.065",

language = "English",

volume = "19",

pages = "3156--3172",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Limited",

number = "10",

}

TY - JOUR

T1 - Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists

T2 - Relationship between absolute configuration and subtype selectivity

AU - Motoshima, Kazunori

AU - Ishikawa, Minoru

AU - Hashimoto, Yuichi

AU - Sugita, Kazuyuki

N1 - Funding Information: The work described in this paper was partially supported by Grants-in-Aid for Scientific Research from The Ministry of Education Culture, Sports, Science and Technology, Japan , and the Japan Society for the Promotion of Science .

PY - 2011/5/15

Y1 - 2011/5/15

N2 - Introduction of an alkylcarboxylic acid unit, which is a partial structure of endogenous peroxisome proliferator-activated receptor (PPAR) ligands, into a phenethylphenylphthalimide skeleton, which possesses liver X receptor (LXR) antagonistic activity, afforded novel PPAR ligands. The results of structure-activity relationship analysis and docking studies led us to the potent PPAR agonists 13c-e. The absolute configuration of 13c-e affects the PPAR subtype selectivity.

AB - Introduction of an alkylcarboxylic acid unit, which is a partial structure of endogenous peroxisome proliferator-activated receptor (PPAR) ligands, into a phenethylphenylphthalimide skeleton, which possesses liver X receptor (LXR) antagonistic activity, afforded novel PPAR ligands. The results of structure-activity relationship analysis and docking studies led us to the potent PPAR agonists 13c-e. The absolute configuration of 13c-e affects the PPAR subtype selectivity.

KW - Molecular design

KW - Nuclear receptor

KW - PPAR agonist

KW - Subtype selectivity

UR - http://www.scopus.com/inward/record.url?scp=79956201861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956201861&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2011.03.065

DO - 10.1016/j.bmc.2011.03.065

M3 - Article

C2 - 21514830

AN - SCOPUS:79956201861

VL - 19

SP - 3156

EP - 3172

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 10

ER -

Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: Relationship between absolute configuration and subtype selectivity

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this